Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Biochimica Et Biophysica Acta
|
February 6, 2013
Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels
David J Adams, Géza Berecki
Cardiovascular Research
|
October 10, 2006
Why the Brugada syndrome is not yet a disease: syndromes, diseases, and genetic causality
Ruben Coronel, Géza Berecki, Tobias Opthof
British Journal of Pharmacology
|
November 19, 2011
Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels
David J Adams, Brid Callaghan, Géza Berecki
Molecular Pharmacology
|
October 23, 2015
Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits
Géza Berecki, Leonid Motin, David J Adams
Neuropharmacology
|
June 2, 2016
Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H
Géza Berecki, Leonid Motin, David J Adams
Neurobiology of Disease
|
March 3, 2023
Biophysical characterization and modelling of SCN1A gain-of-function predicts interneuron hyperexcitability and a predisposition to network instability through homeostatic plasticity
Géza Berecki, Alexander Bryson, Tilman Polster, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 2, 2008
Cardiac channelopathies studied with the dynamic action potential-clamp technique
Géza Berecki, Jan G Zegers, Ronald Wilders, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
July 16, 2014
Dynamic clamp as a tool to study the functional effects of individual membrane currents
Géza Berecki, Arie O Verkerk, Antoni C G van Ginneken, et al.
The Journal of General Physiology
|
April 2, 2014
Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation
Géza Berecki, Jeffrey R McArthur, Hartmut Cuny, et al.
The Journal of Biological Chemistry
|
May 23, 2012
γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins
Hartmut Cuny, Andrew de Faoite, Thuan G Huynh, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Biochimica Et Biophysica Acta
|
February 6, 2013
Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels
David J Adams, Géza Berecki
Cardiovascular Research
|
October 10, 2006
Why the Brugada syndrome is not yet a disease: syndromes, diseases, and genetic causality
Ruben Coronel, Géza Berecki, Tobias Opthof
British Journal of Pharmacology
|
November 19, 2011
Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels
David J Adams, Brid Callaghan, Géza Berecki
Molecular Pharmacology
|
October 23, 2015
Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits
Géza Berecki, Leonid Motin, David J Adams
Neuropharmacology
|
June 2, 2016
Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H
Géza Berecki, Leonid Motin, David J Adams
Neurobiology of Disease
|
March 3, 2023
Biophysical characterization and modelling of SCN1A gain-of-function predicts interneuron hyperexcitability and a predisposition to network instability through homeostatic plasticity
Géza Berecki, Alexander Bryson, Tilman Polster, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 2, 2008
Cardiac channelopathies studied with the dynamic action potential-clamp technique
Géza Berecki, Jan G Zegers, Ronald Wilders, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
July 16, 2014
Dynamic clamp as a tool to study the functional effects of individual membrane currents
Géza Berecki, Arie O Verkerk, Antoni C G van Ginneken, et al.
The Journal of General Physiology
|
April 2, 2014
Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation
Géza Berecki, Jeffrey R McArthur, Hartmut Cuny, et al.
The Journal of Biological Chemistry
|
May 23, 2012
γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins
Hartmut Cuny, Andrew de Faoite, Thuan G Huynh, et al.
Page
of 4